Yifeng Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 1.225 billion yuan, a year-on-year increase of 10.27%
According to the Zhitong Finance APP, Yifeng Pharmacy disclosed its third-quarter report for 2025. The company achieved a revenue of 17.286 billion yuan in the first three quarters, a year-on-year increase of 0.39%; the net profit attributable to the parent company was 1.225 billion yuan, a year-on-year increase of 10.27%; the net profit excluding non-recurring gains and losses was 1.188 billion yuan, a year-on-year increase of 8.80%; the basic earnings per share were 1.01 yuan
According to the Zhitong Finance APP, Yifeng Pharmacy (603939.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 17.286 billion yuan in the first three quarters, a year-on-year increase of 0.39%; the net profit attributable to shareholders was 1.225 billion yuan, a year-on-year increase of 10.27%; the net profit excluding non-recurring gains and losses was 1.188 billion yuan, a year-on-year increase of 8.80%; and the basic earnings per share was 1.01 yuan
